HOLX - Hologic, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
43.40
-0.03 (-0.07%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close43.43
Open43.55
Bid43.43 x 1800
Ask43.44 x 800
Day's Range42.96 - 43.81
52 Week Range35.10 - 48.82
Volume1,700,079
Avg. Volume1,770,550
Market Cap12.642B
Beta (3Y Monthly)1.02
PE Ratio (TTM)N/A
EPS (TTM)-1.53
Earnings DateMay 1, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est47.73
Trade prices are not sourced from all markets
  • How Financially Strong Is Hologic, Inc. (NASDAQ:HOLX)?
    Simply Wall St.3 days ago

    How Financially Strong Is Hologic, Inc. (NASDAQ:HOLX)?

    Hologic, Inc. (NASDAQ:HOLX), a large-cap worth US$13b, comes to mind for investors seeking a strong and reliable stock investment. One reason being its ‘too big to fail’ aura which gives it the appearance of a strong and stable inv...

  • Double Top Spells Trouble for 3 Health Care Stocks
    Investopedia3 days ago

    Double Top Spells Trouble for 3 Health Care Stocks

    Health care stocks have fallen out of favor due to sector rotation and political pressure. Explore three trading ideas to benefit from falling prices.

  • Hologic's Diagnostics Grows Strong, Escalating Costs a Woe
    Zacks4 days ago

    Hologic's Diagnostics Grows Strong, Escalating Costs a Woe

    To fortify its product portfolio, Hologic (HOLX) is working on innovations and product introductions. On this front, Cynosure's R&D pipeline stays robust.

  • Markit11 days ago

    See what the IHS Markit Score report has to say about Hologic Inc.

    Hologic Inc NASDAQ/NGS:HOLXView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is low for HOLX with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding HOLX are favorable with net inflows of $115.08 billion. This was the highest net inflow seen over the last one-year.Error parsing the SmartText Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Were Hedge Funds Right About Flocking Into Hologic, Inc. (HOLX)?
    Insider Monkey16 days ago

    Were Hedge Funds Right About Flocking Into Hologic, Inc. (HOLX)?

    The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We have processed the filings of the more than 700 world-class investment firms that we track and now have access to the collective wisdom contained in […]

  • Business Wire17 days ago

    Hologic to Announce Financial Results for the Second Quarter of Fiscal 2019 on Wednesday, May 1, 2019

    Hologic, Inc. announced today that the Company plans to release its financial results for the second quarter of fiscal 2019 on Wednesday, May 1, 2019, after the market closes.

  • Here's Why You Should Invest in ResMed (RMD) Stock Right Now
    Zacks19 days ago

    Here's Why You Should Invest in ResMed (RMD) Stock Right Now

    ResMed (RMD) continues to invest and expand presence in high-growth markets like China, South Korea, India, Brazil and many countries in Eastern Europe.

  • Genomic Health's New Positive Data to Boost Test Uptake
    Zacks19 days ago

    Genomic Health's New Positive Data to Boost Test Uptake

    Genomic Health (GHDX) continues to see positive developments for Oncotype DX Breast Recurrence Score tests.

  • Business Wire22 days ago

    Hologic Applauds FDA’s Proposed Rule to Update Mammography Regulations Issued Under the Mammography Quality Standards Act (MQSA) of 1992

    Proposed rule highlights the risks of breast density and emphasizes important advances in mammography technology, including 3D mammography

  • Here's Why You Should Buy IDEXX Laboratories (IDXX) Stock
    Zacks23 days ago

    Here's Why You Should Buy IDEXX Laboratories (IDXX) Stock

    The innovation-based, multi-modality global strategy, enabled by enhanced commercial capability, accelerates IDEXX's (IDXX) recurring CAG Diagnostics revenue growth.

  • Neogen (NEOG) Earnings and Revenues Miss Estimates in Q3
    Zacks24 days ago

    Neogen (NEOG) Earnings and Revenues Miss Estimates in Q3

    Continued weakness in the global animal protein market and strongly negative currency conversions posed as headwinds for Neogen (NEOG) in third-quarter fiscal 2019.

  • Zimmer Biomet's FDA 510(k) Nod Widens Robotic Offerings
    Zacks25 days ago

    Zimmer Biomet's FDA 510(k) Nod Widens Robotic Offerings

    With the FDA nod, Zimmer Biomet (ZBH) attains the status of being the first company to boast the 510(k) clearance for Brain, Spine and Knee offerings on a single robotic platform globally.

  • Here's Why You Should Invest in Genomic Health (GHDX) Now
    Zacks26 days ago

    Here's Why You Should Invest in Genomic Health (GHDX) Now

    Having established a strong foothold in the U.S. market, Genomic Health (GHDX) is now making considerable expansion in the international arena.

  • Abbott's New CE Mark to Boost Core Laboratory Diagnostics Arm
    Zacks26 days ago

    Abbott's New CE Mark to Boost Core Laboratory Diagnostics Arm

    Abbott's (ABT) Alinity m diagnostics system and assays will provide increased flexibility and time efficiency while catering to the rising demand for infectious disease testing.

  • National Vision (EYE) Rides on Positive Comps Amid Cost Woes
    Zacks29 days ago

    National Vision (EYE) Rides on Positive Comps Amid Cost Woes

    National Vision (EYE) has been witnessing positive comps owing to increased customer transaction over the last 68 sequential quarters.

  • STERIS (STE) Margin Pressure Hurts, Strategic Growth High
    Zacks29 days ago

    STERIS (STE) Margin Pressure Hurts, Strategic Growth High

    Mounting operating expenses are weighing on the bottom line of STERIS (STE).

  • TeleFlex Announces Multiple Positive Outcomes on UroLift
    Zacks29 days ago

    TeleFlex Announces Multiple Positive Outcomes on UroLift

    A study by TeleFlex (TFX) sheds light on the real-world retrospective data on 30 men suffering urinary retention treated with the UroLift System.

  • Hologic Opens State-Of-The-Art Learning and Experience Centre In Zaventem, Belgium
    Business Wirelast month

    Hologic Opens State-Of-The-Art Learning and Experience Centre In Zaventem, Belgium

    Hologic, Inc. (HOLX), an innovative medical technology company focused on improving women’s health and well-being through early detection and treatment, today opened its first Learning and Experience Centre in Zaventem, Belgium (a municipality neighboring Brussels). The state-of-the-art facility provides comprehensive training for customers, healthcare professionals and employees across Hologic’s Europe, Middle East and Africa (EMEA) region, centralizing the education experience for Hologic’s technologies.

  • Abbott (ABT) Gains Ground on Solid EPD and Diabetes Arms
    Zackslast month

    Abbott (ABT) Gains Ground on Solid EPD and Diabetes Arms

    Abbott's (ABT) EPD business operates in emerging geographies like India, Russia, China and Latin America.

  • Phibro Animal Solid on Global Prospects, Currency Woes Ail
    Zackslast month

    Phibro Animal Solid on Global Prospects, Currency Woes Ail

    Phibro Animal (PAHC) has been gaining from strong volume growth in foreign markets. However, adverse currency movements remain a concern.

  • Henry Schein's New Buyout to Boost Dental Technology Business
    Zackslast month

    Henry Schein's New Buyout to Boost Dental Technology Business

    Henry Schein (HSIC) expects the acquisition to be neutral to its 2019 earnings per diluted share and accretive thereafter.

  • Zimmer Biomet Solid on Global Prospects Despite Price Pressure
    Zackslast month

    Zimmer Biomet Solid on Global Prospects Despite Price Pressure

    Zimmer Biomet (ZBH) has been working to strengthen foothold in emerging markets. However, the company has been facing continued pricing pressure.

  • Myriad's myPath Melanoma Test Awarded Medicare Coverage
    Zackslast month

    Myriad's myPath Melanoma Test Awarded Medicare Coverage

    The latest nod from Medicare Coverage for Myriad's (MYGN) myPath Melanoma test is likely to boost top-line results in the near term.

  • Align Technology (ALGN) Partners With Digital Smile Design
    Zackslast month

    Align Technology (ALGN) Partners With Digital Smile Design

    Align Technology (ALGN) will be integrating Digital Smile Design's methodology in functional and aesthetic dentistry with its end-to-end digital workflow covering iTero scanners and Invisalign system.